Deficiency of the purine metabolic enzyme adenosine deaminase causes severe immunodeficiency. Retroviruses have been reported to decrease the activity of adenosine deaminase, and many retroviruses, including feline leukemia virus, cause immunodeficiency. Levels of purine metabolic enzymes including adenosine deaminase and consequences of adenosine deaminase inhibition were investigated in feline leukemia virus-infected fresh tumor cells and infected and uninfected cell lines. No evidence of virus effect on levels of adenosine deaminase or other purine metabolic enzymes was detected. Neoplastic cells demonstrated considerable heterogeneity of activity levels of purine metabolic enzymes.
AndersonLJHarrettWFHJarrettOLairdHM:
Feline leukemia virus infection of kittens: mortality associated with thymus atrophy of the thymus and lymphoid depletion.
J Natl Cancer Inst47:
807,
1981
2.
BlattJBunnPAJrCarneyDDReamanGSopreyPPoplackDG:
Purine pathway enzymes in the circulating malignant cells of patients with cutaneous T-cell lymphoma.
Br J Haematol52:
97–104,
1982
3.
CarsonDAIizasaTSetoSCarreraCJKubotaMWillisEHWassonDBKajanderO:
Metabolic basis for immune dysfunction in adenosine deaminase deficiency.
Ann NY Acad Sci451:
34–41,
1985
4.
ChiangPKCantoniGLRayDABaderJP:
Reduced levels of adenosine deaminase in chick embryo fibroblasts transformed by rous sarcoma virus.
Biochem Biophys Res Commun78:
336–342,
1977
5.
CohenAHirschhornRHorowitzSDRubinsteinAPolmarSHHongRMartinDWJr:
Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
Proc Natl Acad Sci USA75:
472–476,
1978
6.
CohenMBGlazierRI:
Inhibition of interleukin-2 messenger RNA in mouse lymphocytes by 2′-deoxycoformycin and adenosine metabolites.
Ann NY Acad Sci451:
180–187,
1985
7.
ColemanMSDonofrioJHuttonJJHahnJ:
Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency.
J Biol Chem253:
1619–1626,
1978
8.
CopelanEAJohnsonSCGreverMRTutschkaPJ:
Pharmacologic marrow purging of T-cell leukemia in mice.
Blood71:
1656–1661,
1988
9.
CopelanEARinehartJJLewisMMathesLEOlsenRSagoneAL:
The mechanism of retrovirus suppression of human T cell proliferation in vitro.
J Immunol131:
2017–2020,
1983
10.
CowanMJBradyROWidderKJ:
Elevated erythrocyte adenosine deaminase activity in patients with acquired immunodeficiency syndrome.
Proc Natl Acad Sci USA83:
1089–1091,
1986
11.
DaenanSRojerRASmitJWHalieMRNiewegHO:
Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma/leukemia.
Br J Haematol58:
723–727,
1984
12.
DentP:
Immunosuppression by oncogenic viruses.
Prog Med Virol14:
1–35,
1972
13.
DorandJBonnafousJCFaveroJManiJC:
Purine nucleoside production in mature and immature human lymphocytes.
FEBS Lett124:
88,
1982
14.
FoxRMKeffordRFTrippEHTaylorJW:
G1-Phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
Cancer Res41:
5141–5150,
1981
GiblettER:
ADA and PNP deficiencies: how it all began.
Ann NY Acad Sci451:
1–8,
1985
17.
HardyWDHirshautYHessP:
Detection of the feline leukemia virus and other mammalian oncornaviruses by immunofluorescence.
In:
Unifying Concepts of Leukemia,
ed. DutcherRMCieco-BianchiL,
pp. 778–799.
Karger and
Basel, New York, NY,
1973
18.
HebebrandLCMathesLEOlsenRS:
Inhibition of conconavalin A stimulation of feline lymphocytes by inactivated feline leukemia virus.
Cancer Res37:
4532–4533,
1977
19.
HershfieldMS:
Apparent suicide inactivation of human lymphoblast S-adenosylhomocysteine hydrolase by 2′-deoxyadenosine and adenine arabinoside. A basis for direct toxic effects of analogs of adenosine.
J Biol Chem254:
22–25,
1979
20.
HooverEAMathesLERojkoJLSchallerJPOlsenRG:
Modifications of the immunofluorescence assay for feline leukemia virus group-specific antigens.
Am J Vet Res39:
1877–1880,
1978
21.
JarrettWFHMackeyLJ:
Neoplastic diseases of the haematopoietic and lymphoid tissues.
Cancer Res50:
21–34,
1974
22.
KeffordRFFoxRM:
Purinogenic lymphocytoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.
Cancer Chemother Pharmacol10:
73–76,
1983
23.
KrautEHBournoncle,BAGreverMR:
Low dose deoxycoformycin in the treatment of hairy cell leukemia.
Blood68:
1119–1122,
1986
24.
MaDFSylvestrowicaTAGrangersSMassaiaMFranksRJanossyGHoffbrandV:
Distribution of terminal deoxynucleotidyl transferase and purine degradative and synthetic enzymes in subpopulations of human thymocytes.
J Immunol129:
1430–1435,
1982
25.
MurrayJLLoftinKCMunnCGReubenJMMansellPWAHershEM:
Elevated adenosine deaminase and purine nucleoside Phosphorylase activity in peripheral blood null lymphocytes from patients with acquired immune deficiency syndrome.
Blood65:
1318–1324,
1985
26.
OlsenRGMathesLELewisMGStiffMICopelanEA:
Immunosuppressive properties of a feline retrovirus 15,000 dalton protein.
Prog Clin Biol Res132B:
3–7,
1983
PerrymanLEHooverEAYohnDS:
Immunosuppression in experimental feline leukemia.
J Natl Cancer Inst43:
1357,
1972
29.
PetersGJOosterhofAVeerkampJH:
Adenosine and deoxyadenosine metabolism in mammalian lymphocytes.
Int J Biochem13:
445–455,
1981
30.
PoplackDGBlattJReamanG:
Purine pathway enzyme abnormalities in acute lymphoblastic leukemia.
Cancer Res41:
4821–4823,
1981
31.
RatechHKimJAsofskyRThorbeckeGJHirschhornR:
Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
J Immunol132:
3077–3084,
1984
32.
RojkoJLHooverEAMathesLEOlsenRGSchallerJP:
Pathogenesis of experimental feline leukemia virus infection.
J Natl Cancer Inst63:
759–768,
1979
33.
RojkoJLKocibaGJAbkowitzJLHamiltonKLHardyWDJrIhleJNO'BrienSJ:
Feline lymphomas: immunological and cytochemical characterization.
Cancer Res49:
345–351,
1989
34.
ShipmanCDarchJC:
Absence of adenosine deaminase activity in a mammalian cell line transformed by rous sarcoma virus.
Science200:
1163–1165,
1978
35.
SpiersASMooreDCassilethPA:
Remissions in hairy-cell leukemia with pentostatin (2′-deoxycoformycin).
N Engl J Med316:
825–830,
1987
